NEW YORK – A study has found the weed known as “hash” has medicinal effects on cancer patients, as well as some of the sickest patients on earth.

Researchers say that when given in combination with other treatments, it is a powerful anti-cancer drug that may have an impact on treating cancer patients.

The research, published in the journal Cancer Research, found that in some cancer patients who were given “hash,” the cancer cells were able to “cure” the cancer.

“The marijuana-derived compounds, called cannabinoids, are potent and have been shown to have anti-inflammatory and antioxidant properties.

It may also have antiemetic properties,” the researchers wrote.

“However, as the drugs themselves are not known to be able to cure cancer, it remains unknown if they have any medicinal value.”

Researchers found that when the patients were given hash and chemotherapy, they had lower rates of cancer recurrence and less severe side effects.

The study was conducted at the University of California San Francisco and the National Institute on Drug Abuse (NIDA), which funded the study.

Researchers said that because there is no proven cancer-fighting properties for marijuana, the study is the first to explore whether it can also have an effect on cancer cells.

“It is very interesting that we were able … to find this in cancer patients,” said study researcher Dr. James M. O’Connor, an assistant professor of medicine at the USC San Francisco Medical School.

“It’s a pretty exciting finding.

It really opens up a lot of new questions about this.”

In some cases, the cancer had already spread beyond the patient’s body.

In one of the studies, patients who had cancer were given a mixture of marijuana and chemotherapy.

The researchers found that those who had received the cancer-killing combination of drugs experienced a 30 percent decrease in their cancer risk and a 40 percent decrease from a baseline cancer rate of 16.7 percent.

The researchers say that the finding could have therapeutic potential for cancer patients suffering from other types of tumors.

“This is the only study to show this effect, and it’s very promising, and the research is still ongoing,” Dr. O`Connor said.

“But we still don’t have all the answers.”

Dr. O�Connor also said that some patients may benefit from taking a higher dose of hash and possibly reducing chemotherapy doses.

In the study, the researchers looked at a group of patients who have been diagnosed with lung cancer.

The patients were divided into two groups, one that received a combination of chemotherapy and a marijuana-based drug, and one that did not.

In both groups, they were given daily injections of a compound called delta9-tetrahydrocannabinol (THC).

The study found that patients who received the THC injections experienced a 15 percent decrease on their cancer rate and a 30% decrease in cancer recurrences.

In patients who did not receive THC, the drug was not able to help the patients get rid of the cancer or slow its progression.

In addition, patients receiving THC injections showed a 30-percent increase in the tumor-killing potency of their chemotherapy, Dr. M. R. Pfeiffer, a researcher at the NIDA, said in a press release.

Dr. Peeves said that even though it may be difficult to find marijuana that can help people with lung cancers, the research points to the fact that there is a growing demand for marijuana for therapeutic use.

“We’re seeing this for the first time that this cannabinoid can be useful for patients with lung and other types, and there’s lots of research out there,” Dr Peevell said.